Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018

Size: px
Start display at page:

Download "Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018"

Transcription

1 Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1

2 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided Page 5 5 Samples Page 7 6 Results and turnaround times Page 9 7 Quality aspects Page 9 8 Request forms Page Page 2

3 Introduction The Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) is commissioned by National Services Scotland (NSS) to provide a national reference service for the management of bacterial sexually transmitted infections throughout Scotland. It is located in the Department of Laboratory Medicine at the Royal Infirmary of Edinburgh, NHS Lothian and is accredited by the Clinical Pathology Accreditation (UK) Ltd. This User Manual describes the services provided by SBSTIRL, how to send samples to the laboratory and how to contact the laboratory. This Manual is intended for use by healthcare professionals working in Scotland accessing SBSTIRL s services. It is not intended for use by patients. Page 3

4 Contact details Postal address Scottish Bacterial STI Reference Laboratory (SBSTIRL) Microbiology Royal Infirmary of Edinburgh 51 Little France Crescent Edinburgh EH16 4SA HaysDX address DX , Edinburgh 96EH Office phone number Generic address NHS Lothian Department of Laboratory Medicine website Fax number We do not accept or send faxes. Staff contact details Dr Kate Templeton Director Dr Ewan Olson Medical lead Dr Kate Cuschieri R&D lead Dr Jill Shepherd Clinical Scientist Ms Anne-Marie Logue Administrator Opening hours Core working hours are Monday to Friday 09:00 to 17:00. The laboratory is not open on weekends or NHS Lothian public holidays. Page 4

5 Services provided The following services are provided for referred isolates of presumptive Neisseria gonorrhoeae: Identification of problem isolates Antibiotic resistance surveillance Molecular typing of gonococci by Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST) and, where appropriate, by other methods Characterisation of medico-legal isolates Identification of N. gonorrhoeae by nucleic acid amplification test (NAAT) for non-viable isolates. The following tests are performed on clinical specimens: Supplemental NAAT for N. gonorrhoeae (GC NAAT) NG-MAST on GC NAAT positive specimens Real-time PCR for Lymphogranuloma venereum (LGV) on Chlamydia-positive samples from cases of suspected LGV Detection of macrolide and quinolone resistance by sequencing in Mycoplasma genitalium-pcr positive samples The SBSTIRL also provides these general services: Clinical and microbiological advice Assessment and development of new methodologies Participation in national/international surveillance and quality assurance projects Education, training, audit and collaborative research Maintenance of isolate and sample archive to facilitate research and service development Please note that Treponema pallidum testing, either by serology or PCR is NOT part of the reference laboratory service. However, we are happy to provide general advice to laboratories regarding testing methodology. Tests N. gonorrhoeae susceptibility testing Susceptibility to 7 antibiotics (Azithromycin, Ceftriaxone, Cefixime, Penicillin, Ciprofloxacin, Spectinomycin and Tetracycline) is determined. EUCAST breakpoints are used. Supplemental NAAT for N. gonorrhoeae A second test that targets a different specific gene is required to ensure a true positive GC result. We provide alternative assays to ensure that whatever the first GC NAAT used at your laboratory, there will be a suitable second test available for supplemental testing. The assay currently in use is an in-house PCR which targets Page 5

6 the PorA pseudogene and the 16s rrna gene. This service is currently under review. Any changes made will communicated to all users. NG-MAST sequence typing A proportion of cultured isolate and NAAT positive specimens are selected for sequence typing by Sanger sequencing. LGV PCR A real-time PCR to detect the polymorphic membrane protein H gene is performed. M. genitalium resistance testing by sequencing Macrolide and quinoline resistance in clinical specimens is determined by Sanger sequencing. Referred tests Occasionally, specimens and isolates may be referred to Public Health England, Centre for Infections, Colindale, for further specialist testing unavailable in Scotland. All such referrals should be made through SBSTIRL in order to be funded by NSS. Additional testing Gonococcal isolates and medicolegal specimens are stored indefinitely, and DNA extracts from specimens for NAAT are stored for at least one year. For retrospective testing or typing within these time-frames, please contact the laboratory. Page 6

7 Samples Request information Please complete the relevant SBSTIRL request form (see end of Manual). There are separate request forms for submission of N. gonorrhoeae cultures, specimens for supplemental N. gonorrhoeae NAAT, for LGV real time PCR, and for M. genitalium resistance testing by sequencing. All specimens must be labelled with the following information: Unique Identifier (Surname & Forename/CHI number/nash number) Date of birth Sender s Laboratory Number All specimens must be accompanied by the appropriate request form with the following information: Patient s unique Identifier (Surname & Forename/CHI number/nash number) Patient s date of birth and gender Specimen type/site Sender s Laboratory Number Location of Sender Any relevant clinical information Samples not received with an appropriately completed request form, or that are leaking may be discarded. Sample types N. gonorrhoeae culture Chocolate agar slope of the culture after a minimum of 6 hours incubation at 35-37ºC, 5% CO 2. or Overnight growth of organism transferred to an Amies charcoal agar transport swab Supplemental N. gonorrhoeae NAAT Any positive or equivocal GC NAAT specimen in any media as recommended by the NAAT manufacturer. Please indicate on supplemental GC NAAT request form which test has already been performed and the result. N. gonorrhoeae typing directly from a clinical specimen Any NAAT specimen which is GC positive by two different NAATs or two different targets within the same NAAT Page 7

8 LGV PCR Any NAAT specimen that is chlamydia positive meeting the following criteria: specimens from symptomatic patients, contacts of LGV and chlamydia-positive swabs from HIV-positive patients. M. genitalium resistance testing Any NAAT specimen that is M. genitalium positive. Please indicate which collection medium the sample has been transported in. Sample transportation Specimens should be appropriately packaged in accordance with current regulations. Please ensure N. gonorrhoeae cultures arrive Monday-Friday. Do not send on Fridays. Viability in transit cannot be guaranteed beyond 2 days. Page 8

9 Results and turn around times It is NHS Lothian Laboratory Medicine policy that results should be returned via a secure address such Paper copies of reports can be sent via Royal Mail by prior arrangement. For gonococcal cultures, a report of confirmation of identity and antimicrobial susceptibility is issued, followed by a final report including sequence type in those selected for typing. NAAT reports are issued as soon as possible. For NAAT-positive samples an updated report containing sequence typing data may be issued at a later date. LGV PCR reports are issued as soon as possible. M. genitalium reports are issued as soon as possible. Turnaround times Test Turnaround time (days) GC identification and antibiotic susceptibility testing 7 Supplemental GC NAAT 3 NG-MAST sequence typing 90 LGV PCR 7 M. genitalium resistance testing 14 Turnaround time excludes weekends and public holidays Quality aspects SBSTIRL is accredited by the Clinical Pathology Accreditation (UK) Ltd as part of Microbiology at the Royal Infirmary of Edinburgh. Any technical queries about the SBSTIRL assays can be made to Lothian.STIRefLab@nhs.net Complaints can be discussed with Kate Templeton or Jill Shepherd. The NHS Lothian Department of Laboratory Medicine Compliance Manager is Nadine Wilkinson Nadine.Wilkinson@nhslothian.scot.nhs.uk Page 9

10 SBSTIRL lab no Neisseria gonorrhoeae identification and antibiotic susceptibility Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) Microbiology Department, Royal Infirmary of Edinburgh 51 Little France Crescent, Edinburgh EH16 4SA Hays DX: DX , Edinburgh 96EH FROM Consultant Referring lab Address Telephone number PATIENT DETAILS Surname: Clinic number / CHI: Forename: Date of Birth: Sex: M / F / U Category of patient: GUM GP Hospital Other SPECIMEN Your lab number: Date collected: Date sent to SBSTIRL: Sample type: Urethral Cervical Rectal Throat Additional Information Page 10

11 SBSTIRL lab no Supplemental Neisseria gonorrhoeae NAAT Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) Microbiology Department, Royal Infirmary of Edinburgh 51 Little France Crescent, Edinburgh EH16 4SA Hays DX: DX , Edinburgh 96EH FROM Consultant Referring lab Address Telephone number PATIENT DETAILS Surname: Clinic number / CHI: Forename: Date of Birth: Sex: M / F / U Category of patient: GUM GP Hospital Other SPECIMEN Your lab number: Date collected: Date sent to SBSTIRL: Sample type: Urethral Cervical Urine Vulvo/vaginal Rectal Throat TESTING Confirmation of initial screen result NG-MAST sequence typing only (already confirmed by sender) Screening GC NAAT test used: Abbott Roche Cobas 4800 BD Probetec / Viper Hologic Aptima Combo Qiagen Ct/Cq/DC test value: Page 11

12 SBSTIRL lab no Lymphogranuloma Venereum (LGV) PCR Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) Microbiology Department, Royal Infirmary of Edinburgh 51 Little France Crescent, Edinburgh EH16 4SA Hays DX: DX , Edinburgh 96EH FROM Consultant Referring lab Address Telephone number PATIENT DETAILS Surname: Clinic number / CHI: Forename: Date of Birth: Sex: M / F / U Category of patient: GUM GP Hospital Other SPECIMEN Your lab number: Date collected: Date sent to SBSTIRL: Sample type: Urethral Cervical Urine Vulvo/vaginal Rectal Throat TESTING REFERRED SAMPLES MUST BE CHLAMYDIA TRACHOMATIS POSITIVE Screening Chlamydia trachomatis NAAT test used: Abbott Roche Cobas 4800 BD Probetec / Viper Hologic Aptima Combo Qiagen REASON FOR REQUEST Symptomatic Proctitis Inguinal lymphadenopathy Contact of confirmed LGV case Chlamydia trachomatis positive sample from HIV positive MSM Page 12

13 SBSTIRL lab no Mycoplasma genitalium resistance testing Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) Microbiology Department, Royal Infirmary of Edinburgh 51 Little France Crescent, Edinburgh EH16 4SA Hays DX: DX , Edinburgh 96EH FROM Consultant Referring lab Address Telephone number PATIENT DETAILS Surname: Clinic number / CHI: Forename: Date of Birth: Sex: M / F / U Category of patient: GUM GP Hospital Other SPECIMEN Your lab number: Date collected: Date sent to SBSTIRL: Sample type: Urethral Cervical Urine Vulvo/vaginal Rectal Throat TESTING Screening M. genitalium NAAT assay used: SpeeDx Hologic Aptima In-house PCR Ct/Cq/DC test value: TREATMENT HISTORY Azithromycin Moxifloxacin Doxycycline Page 13

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Report for the period January - December 2011

Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Report for the period January - December 2011 Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Report for the period January - ember 211 Kirstine Eastick PhD FRCPath (Director) SBSTIRL, Microbiology Edinburgh

More information

Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011

Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011 Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011 Molecular testing for gonorrhoea working group (see Appendix) Prepared by Kirstine Eastick March 2012-1

More information

Scottish E. coli O157/Shiga toxin-producing E. coli Reference Laboratory

Scottish E. coli O157/Shiga toxin-producing E. coli Reference Laboratory Scottish E. coli O157/Shiga toxin-producing E. coli Reference Laboratory 1 Authors: SERL68:Version L. Allison 6 Issue date & M. 27/09/2017 Hanson This is an electronic document Authors: L. Allison which

More information

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Selena Singh Guy s and St Thomas NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool Performance of ceftriaxone 500mgcontaining

More information

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.? BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection

More information

UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland

UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH Dr Arlo Upton Clinical Microbiologist Labtests Auckland Talk outline Chlamydia trachomatis NAAT What does a positive test mean Interpreting low level positives

More information

Validation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae

Validation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae Proposal Validation of the MALDI-TOF for the Identification of Neisseria gonorrhoeae Laboratory Director Sandip H. Shah, Ph.D. 517-335-8063 517-335-8051 (fax) ShahS@Michigan.gov Acting Director, Division

More information

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and

The objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and 1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship

More information

Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing

Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing Recommendations from the an expert consultation meeting held at CDC January 13-15,

More information

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology

More information

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011 Sexually Transmitted Infection surveillance in Northern Ireland 2012 An analysis of data for the calendar year 2011 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:

More information

Professor Jonathan Ross

Professor Jonathan Ross SECOND JOINT CONFERENCE OF BHIVA AND BASHH 2010 Professor Jonathan Ross Whittall Street Clinic, Birmingham COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Professor Ross has received

More information

Lymphogranuloma Venereum (LGV) Surveillance Project

Lymphogranuloma Venereum (LGV) Surveillance Project Lymphogranuloma Venereum (LGV) Surveillance Project Lymphogranuloma venereum (LGV) is a systemic, sexually transmitted disease (STD) caused by a type of Chlamydia trachomatis (serovars L1, L2, L3) that

More information

OAML Guideline on the Investigation of Genital Tract Infections November, 2015

OAML Guideline on the Investigation of Genital Tract Infections November, 2015 OAML Guideline on the Investigation of Genital Tract Infections November, 2015 1. Purpose The purpose of this guideline is to provide ordering clinicians with a clear and concise reference for the investigation

More information

Clinical Guidelines Update (aka Know Your NAATs)

Clinical Guidelines Update (aka Know Your NAATs) Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz

More information

New CT/GC Tests. CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009

New CT/GC Tests. CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009 CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009 Richard Steece, Ph.D., D(ABMM) DrRSteece@aol.com New CT/GC Tests New Nucleic Acid Amplification Tests (NAATs) for

More information

FEDERAL PUBLIC SERVICE, HEALTH, FOOD CHAIN SECURITY AND ENVIRONMENT CLINICAL BIOLOGY COMMISSION CLINICAL BIOLOGY SECTION

FEDERAL PUBLIC SERVICE, HEALTH, FOOD CHAIN SECURITY AND ENVIRONMENT CLINICAL BIOLOGY COMMISSION CLINICAL BIOLOGY SECTION IPH J. Wytsmanstreet 14 B-1050 Brussels FEDERAL PUBLIC SERVICE, HEALTH, FOOD CHAIN SECURITY AND ENVIRONMENT CLINICAL BIOLOGY COMMISSION CLINICAL BIOLOGY SECTION External Quality Assessment for Molecular

More information

5/1/2017. Sexually Transmitted Diseases Burning Questions

5/1/2017. Sexually Transmitted Diseases Burning Questions Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial

More information

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set Sexually Transmitted Infection, including HIV, 213 Health Protection Scotland Slide Set Enhanced surveillance systems are employed to give more detailed information on the epidemiology of infectious syphilis

More information

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018

New diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018 New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with

More information

4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE

4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE Laboratory Testing Update Specimen Transport Changes dated 12-24-14 SEH Laboratory is making significant changes to specimen transports! The Laboratory is introducing new testing platforms along with working

More information

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection A Elgalib, A Skingsley, O Dosekun, S Alexander, CYW Tong, JA White. Ali Elgalib Consultant in GUM/HIV

More information

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB

More information

Answers to those burning questions -

Answers to those burning questions - Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department

More information

Treatment resistant STIs relevant to MSM

Treatment resistant STIs relevant to MSM Treatment resistant STIs relevant to MSM David A. Lewis FRCP (UK) PhD Centre for HIV and STIs National Institute for Communicable Diseases (NHLS) Johannesburg, South Africa Regional Director, IUSTI Africa

More information

What's the problem? - click where appropriate.

What's the problem? - click where appropriate. STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female

More information

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Dr Paddy Horner Consultant Senior Lecturer University of Bristol Advances in STI diagnostics Rapid expansion in on-line STI testing Outstripping NHS expert advice Increasing

More information

Learning Objectives. STI Update. Case 1 6/1/2016

Learning Objectives. STI Update. Case 1 6/1/2016 Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe

More information

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

Controls for Chlamydia trachomatis and Neisseria gonorrhoea Controls for Chlamydia trachomatis and Neisseria gonorrhoea Mark Manak, Ph.D., SeraCare Life Sciences Gaithersburg, MD USA SoGAT Clinical Diagnostic Meeting NIBSC, South Mimms, UK June 25, 2008 C. trachomatis

More information

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health Christchurch Dr Edward Coughlan Clinical Director Christchurch Sexual Health Christchurch 16:30-17:25 WS #48: Mycoplasma Genitalium - The New Black 17:35-18:30 WS #58: Mycoplasma Genitalium - The New Black (Repeated)

More information

Chlamydia trachomatis

Chlamydia trachomatis Chlamydia trachomatis 2012 EQA Programme A Final Report QAB004101 (CTDNA12A) Dr Anton M van Loon Scientific Experts on behalf of QCMD Report authorised by the QCMD Executive in May 2012 A UKAS accredited

More information

Controls for Chlamydia trachomatis and Neisseria gonorrhoea

Controls for Chlamydia trachomatis and Neisseria gonorrhoea Controls for Chlamydia trachomatis and Neisseria gonorrhoea Mark Manak, Ph.D., Phil Moen, Ph.D., Bharathi Anekella, Ph.D SeraCare Life Sciences Gaithersburg, MD USA SoGAT Clinical Diagnostic Meeting NIBSC,

More information

CHLAMYDIA/GC AMPLIFIED RNA ASSAY

CHLAMYDIA/GC AMPLIFIED RNA ASSAY Lab Dept: Test Name: Microbiology/Virology CHLAMYDIA/GC AMPLIFIED RNA ASSAY General Information Lab Order Codes: CGRNA Synonyms: CPT Codes: Test Includes: Chlamydia trachomatis/neisseria gonorrhoeae by

More information

Chlamydia trachomatis

Chlamydia trachomatis Chlamydia trachomatis 2012 EQA Programme A Final Report QAB004101 (CTDNA12A) Version 2 Dr Anton M van Loon Scientific Experts on behalf of QCMD Report authorised by the QCMD Executive in May 2012 A UKAS

More information

Nucleic acid amplification testing for Neisseria gonorrhoeae where are we going?

Nucleic acid amplification testing for Neisseria gonorrhoeae where are we going? Nucleic acid amplification testing for Neisseria gonorrhoeae where are we going? David Whiley QPID Laboratory, Queensland Children s Medical Research Institute, Children s Health Service District, and

More information

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE MYCOPLASMA GENITALIUM A PRACTICAL GUIDE DR JENNY HAYWARD FRANZCOG FACHSHM NEW ZEALAND SEXUAL HEALTH CONFERENCE SATURDAY 9 TH SEPTEMBER 1 ACKNOWLEDGE FRUSTRATIONS AWARENESS EVOLVING AREA TESTING OFTEN MULTIPLE

More information

COMMUNICABLE DISEASE REPORT

COMMUNICABLE DISEASE REPORT COMMUNICABLE DISEASE REPORT Quarterly Report Volume 29, Number 3 September 2012 Sexually Transmitted and Bloodborne Infections Reporting All laboratory confirmed sexually transmitted and bloodborne infections

More information

STIs- REVISION. Prof A A Hoosen

STIs- REVISION. Prof A A Hoosen STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex

More information

DETECTION OF NEISSERIA GONORRHOEAE USING MOLECULAR METHODS

DETECTION OF NEISSERIA GONORRHOEAE USING MOLECULAR METHODS NATIONAL STANDARD METHOD DETECTION OF NEISSERIA GONORRHOEAE USING MOLECULAR METHODS QSOP 62 Issued by Standards Unit, Department for Evaluations,Standards and Training Centre for Infections Issue no: 1

More information

Emergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes

Emergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes Emergence et impact clinique de la résistance aux antibiotiques chez Chlamydia trachomatis, Neisseria gonorrhoeae, les mycoplasmes Cécile Bébéar French National Center for bacterial STIs Bordeaux University

More information

MYCOPLASMA GENITALIUM FEASABILITY AND PITFALLS OF ADJUNCT TESTING FOR MACROLIDE RESISTANCE (a.k.a. no test is 100%)

MYCOPLASMA GENITALIUM FEASABILITY AND PITFALLS OF ADJUNCT TESTING FOR MACROLIDE RESISTANCE (a.k.a. no test is 100%) MYCOPLASMA GENITALIUM FEASABILITY AND PITFALLS OF ADJUNCT TESTING FOR MACROLIDE RESISTANCE (a.k.a. no test is 100%) Collette Bromhead, Peter Lowe, Litty Tan, Arlo Upton The New Zealand Sexual Health Society

More information

Area Laboratory Service

Area Laboratory Service THIS IS A CONTROLLED DOCUMENT. DO NOT COPY Area Laboratory Service Organisational Unit: Title: Ref No: Version No: Date Issued: Author: Authorised by: Review date: Location of this Copy : Microbiology

More information

Nothing to disclose.

Nothing to disclose. Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence

More information

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2016 Sexually Transmitted Infection surveillance in Northern Ireland 2017 An analysis of data for the calendar year 2016 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:

More information

Management of NGU (Non-gonococcal urethritis)

Management of NGU (Non-gonococcal urethritis) Management of NGU (Non-gonococcal urethritis) First line Doxycycline 100mg po bd for 7 days (contra-indicated in pregnancy) Alternative regimens Azithromycin 1G po stat Azithromycin 500mg po stat, then

More information

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think?

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think? Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think? Mr Daniel Ward 1 Dr Meg Boothby 2 Dr Penny Goold 2 Dr Emma Hathorn 2 1 University of Birmingham, UK 2 Whittall

More information

Appendix B Recommendation for enhanced surveillance of gonococcal infection

Appendix B Recommendation for enhanced surveillance of gonococcal infection Appendix B Recommendation for enhanced surveillance of gonococcal infection Enhanced gonococcal infection surveillance Recommendation for enhanced surveillance of gonorrhoea in the context of the increase

More information

Sexually transmitted infections (in women)

Sexually transmitted infections (in women) Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:

More information

STDs and Hepatitis C

STDs and Hepatitis C STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk

More information

6. Gonococcal antimicrobial susceptibility

6. Gonococcal antimicrobial susceptibility 6. Gonococcal antimicrobial susceptibility Key points Gonococcal AMR continues to increase worldwide and could lead to a pandemic of extensively drug-resistant (XDR) N. gonorrhoeae with serious public

More information

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.

More information

ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA

ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA ANALYSIS OF MYCOPLASMA GENITALIUM STRAINS ISOLATED FROM PREGNANT WOMEN AT AN ACADEMIC HOSPITAL IN PRETORIA, SOUTH AFRICA Mafunise M 1, Le Roux MC 1, de Villiers BE 1, Ditsele RMM 1,2 1 Department of Microbiological

More information

TDL Sexual Health 2019

TDL Sexual Health 2019 TDL Sexual Health 019 Sexual Health Screening services continue to become easier to access for everyone, with testing and results becoming available more quickly through both private, NHS clinics, and

More information

Industry Sponsored Symposia. Québec City, CANADA JULY 10 TO 13,

Industry Sponsored Symposia. Québec City, CANADA JULY 10 TO 13, 19th biennial conference of the International Society for sexually transmitted diseases Research Québec City, CANADA JULY 10 TO 13, 2011 Industry Sponsored Symposia www.isstdrquebec2011.com SUNDAY JULY

More information

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council

STI & HIV screening in Primary Care. Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council STI & HIV screening in Primary Care Dr Paddy Horner Consultant Senior Lecturer University of Bristol Annette Billing Public Health, Bristol Council Outline Why Screen Advances in diagnostics how can we

More information

Internationell utblick STI/HIV i världen

Internationell utblick STI/HIV i världen Internationell utblick STI/HIV i världen Magnus Unemo, PhD, Assoc. Professor, Director Swedish Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology Örebro University

More information

HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2010

HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2010 HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 21 Health Protection Surveillance Centre, www.hpsc.ie Version 1. May 212 Table of Contents Acknowledgements... 5 Key Points... 5 Introduction... 7 Methods...

More information

Scotland s Sexual Health Information, SSHI Health Protection Scotland Slide Set

Scotland s Sexual Health Information, SSHI Health Protection Scotland Slide Set Scotland s Sexual Health Information, SSHI 21 Health Protection Scotland Slide Set Data on positive diagnoses of selected STIs, including HIV, are reported from all microbiological laboratories throughout

More information

BEIPH Final Report. EQA Programme 2011 Chlamydia trachomatis (CTDNA11A) William G Mackay on behalf of QCMD and its Scientific Council April 2011

BEIPH Final Report. EQA Programme 2011 Chlamydia trachomatis (CTDNA11A) William G Mackay on behalf of QCMD and its Scientific Council April 2011 BEIPH Final Report EQA Programme 2011 Chlamydia trachomatis (CTDNA11A) William G Mackay on behalf of QCMD and its Scientific Council April 2011 Not to be reproduced or quoted without permission of QCMD.

More information

Résistance bactérienne au cours des Infections Sexuellement Transmissibles Cécile Bébéar

Résistance bactérienne au cours des Infections Sexuellement Transmissibles Cécile Bébéar Résistance bactérienne au cours des Infections Sexuellement Transmissibles Cécile Bébéar French Na*onal Center for bacterial STIs Bordeaux University hospital, Bordeaux, France University of Bordeaux,

More information

Update on Sexually Transmitted Infections among Persons Living with HIV

Update on Sexually Transmitted Infections among Persons Living with HIV Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and

More information

2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS. Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham

2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS. Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham 2014 CDC GUIDELINES CHLAMYDIA & GONORRHEA DIAGNOSTICS Barbara Van Der Pol, PhD, MPH University of Alabama at Birmingham DISCLOSURES Honorarium, Speaking Fees or Research Support Atlas Genetics BD Diagnostics

More information

STI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research

STI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research Teodora Wi Geneva, 28 August 2017 STI Treatment Guidelines Teodora Wi Training Course in Sexual and Reproductive Health Research 2017 Twitter @HRPresearch 1 STI treatment guidelines Neisseria gonorrhoeae

More information

Sexually transmitted infections (in women)

Sexually transmitted infections (in women) Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:

More information

Mycoplasma Genitalium: Get to Know the Hidden STI

Mycoplasma Genitalium: Get to Know the Hidden STI Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/womens-health-update/mycoplasma-genitalium-get-to-know-hiddensti/9501/

More information

LYMPHOGRANULOMA VENEREUM PRESENTING AS PERIANAL ULCERATION: AN EMERGING CLINICAL PRESENTATION?

LYMPHOGRANULOMA VENEREUM PRESENTING AS PERIANAL ULCERATION: AN EMERGING CLINICAL PRESENTATION? LYMPHOGRANULOMA VENEREUM PRESENTING AS PERIANAL ULCERATION: AN EMERGING CLINICAL PRESENTATION? Tajinder K Singhrao, Elizabeth Higham, Patrick French To cite this version: Tajinder K Singhrao, Elizabeth

More information

HPS Weekly Report. Current notes. Contents. 26 September 2017 Volume 51 No. 2017/38 ISSN (Online)

HPS Weekly Report. Current notes. Contents. 26 September 2017 Volume 51 No. 2017/38 ISSN (Online) HPS Weekly Report Volume 51 No. 2017/38 ISSN 1753-4224 (Online) Contents Current notes Legionnaires disease, Dubai - ECDC risk assessment 331 Antibacterial agents in clinical development - WHO report 332

More information

STIs: Practical Aspects of Management

STIs: Practical Aspects of Management STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS

More information

OBJECTIVES. Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections

OBJECTIVES. Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections OBJECTIVES I. Appreciate the changing epidemiology of trichomoniasis and clinician ordering patterns on the basis of improved

More information

Mycoplasma genitalium:

Mycoplasma genitalium: Mycoplasma genitalium: What is it and why should we care? Lisa E. Manhart, PhD, MPH rwpoll.com uwecho Last Updated: 09-26-2016 uwptc@uw.edu uwptc.org 206-685-9850 Disclosures Service on a scientific advisory

More information

Gonorrhea Antimicrobial Resistance in Alberta. Gonorrhea Antimicrobial Resistance Review

Gonorrhea Antimicrobial Resistance in Alberta. Gonorrhea Antimicrobial Resistance Review 2011 Review in Alberta Alberta Gonorrhea AMR Surveillance Working Group November 2013 2011 Review Background Gonorrhea remains one of the oldest infections known to man. Infections can result in significant

More information

Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet. Jordan, Stephen J. MD, PhD; Geisler, William M.

Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet. Jordan, Stephen J. MD, PhD; Geisler, William M. Azithromycin for Rectal Chlamydia: Is it Time to Leave Azithromycin on the Shelf?...Not Yet Jordan, Stephen J. MD, PhD; Geisler, William M. MD, MPH From the Department of Medicine, University of Alabama

More information

Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections

Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections Emerging Laboratory Diagnostic Options for Sexually-transmitted Infections Erik Munson Wheaton Franciscan Laboratory Marquette University Milwaukee, Wisconsin 1 OBJECTIVES I. Appreciate the changing epidemiology

More information

Manchester Cytology Centre Synovial Fluid Analysis Service User Manual 2016

Manchester Cytology Centre Synovial Fluid Analysis Service User Manual 2016 Page 1 of 13 Directorate of Laboratory Medicine Manchester Cytology Centre Synovial Fluid Analysis Service User Manual 2016 Page 2 of 13 Table of contents Table of contents... 2 1. About us... 3 1.1 Opening

More information

Services for GLBTQ Youth

Services for GLBTQ Youth Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual

More information

Chlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University

Chlamydia Trachomatis and Neisseria Gonorrhoeae. Khalil G. Ghanem, MD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Technical Bulletin No. 98b

Technical Bulletin No. 98b CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 98b Chlamydia trachomatis and Neisseria gonorrhoeae Dual Target PCR Assay UPDATED Specimen Requirements October 13, 2016 Contact: Susan

More information

Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document

Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document Cheshire and Merseyside Sexual Health Network STI Care Pathways explanatory document Clinical STI/HIV Care Pathway assumes appropriate competency verified (flow chart and explanatory notes to be read together)

More information

Manchester Cytology Centre Synovial Fluid Analysis Service User Manual 2017/2018

Manchester Cytology Centre Synovial Fluid Analysis Service User Manual 2017/2018 Page 1 of 12 Author: Sarah Ferris Directorate of Laboratory Medicine Manchester Cytology Centre Synovial Fluid Analysis Service User Manual 2017/2018 Page 2 of 12 Author: Sarah Ferris Table of contents

More information

REPORT ON SEXUALLY TRANSMITTED INFECTIONS IN CANADA: 2012

REPORT ON SEXUALLY TRANSMITTED INFECTIONS IN CANADA: 2012 REPORT ON SEXUALLY TRANSMITTED INFECTIONS IN CANADA: 2012 CENTRE FOR COMMUNICABLE DISEASES AND INFECTION CONTROL PUBLIC HEALTH AGENCY OF CANADA PROTECTING CANADIANS FROM ILLNESS TO PROMOTE AND PROTECT

More information

Sexually Transmitted Disease Treatment Tables

Sexually Transmitted Disease Treatment Tables Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The

More information

Sexually transmitted infections

Sexually transmitted infections Sexually transmitted infections Dr Caroline CHARLIER-WOERTHER Université Paris Descartes Paris, France Learning objectives Counsel patients about the risk of STD Know how to diagnose and treat a sexuallytransmitted

More information

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS

RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS RISING TO THE GLOBAL CHALLENGE... GONORRHOEA, SYPHILIS AND OTHER BUGS Warning: contains sexual themes and references! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz Updates

More information

Emerging Issues in STDs and Resistance

Emerging Issues in STDs and Resistance Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-

More information

2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing

2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing 2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing Joan M. Chow, MPH, DrPH Surveillance, Epidemiology, Assessment & Evaluation Section Sexually Transmitted Disease Control Branch Division

More information

Moving Forward Sexually Transmitted Infections, including HIV, in Scotland 2005

Moving Forward Sexually Transmitted Infections, including HIV, in Scotland 2005 Moving Forward Sexually Transmitted Infections, including HIV, in Scotland 25 NHS National Services Scotland /Crown Copyright 26 First published November 26 ISBN 1-873772-19-X Brief extracts from this

More information

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY MHD II, Session 6, STUDENT Copy Page 1 CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6 Friday, MARCH 18, 2016 STUDENT COPY Resource for cases: ACP Medicine (Scientific American Medicine) - Vaginitis

More information

INFECTIOUS SYPHILIS NOTIFICATION FORM

INFECTIOUS SYPHILIS NOTIFICATION FORM INFECTIOUS SYPHILIS NOTIFICATION FORM This is a Schedule 1, Section C disease notifiable to the Medical Officer of Health under Sections 74 and 74AA of the Health Act 1956 using non-identifiable data.

More information

UK Standards for Microbiology Investigations

UK Standards for Microbiology Investigations UK Standards for Microbiology Investigations Blood Borne Virus Testing in Dialysis Patients Issued by the Standards Unit, Microbiology Services, PHE Virology V 10 Issue no: 2 Issue date: 27.04.15 Page:

More information

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations Dear User, ISSUE: M008 DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations In order to comply with national quality guidance and as part of our

More information

STI Diagnostics Redesign. HVS and Chlamydia Resource Pack

STI Diagnostics Redesign. HVS and Chlamydia Resource Pack Important! 1. This information is intended to support practitioners in the management of common sexual health problems and it is therefore essential that each doctor and nurse receives a copy. 2. Future

More information

STI in British Columbia: Annual Surveillance Report

STI in British Columbia: Annual Surveillance Report STI in British Columbia: Annual Surveillance Report 212 Contact Information BC Centre for Disease Control Clinical Prevention Services 655 West 12th Avenue Vancouver BC V5Z 4R4 Phone: 64-77-5621 Fax: 66-77-564

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Royal Liverpool & Broadgreen University Hospitals NHS Trust Department of Virology Liverpool Clinical Laboratories Royal Liverpool and Broadgreen

More information

REPORT ON THE ENHANCED SURVEILLANCE OF ANTIMICROBIAL-RESISTANT GONORRHEA

REPORT ON THE ENHANCED SURVEILLANCE OF ANTIMICROBIAL-RESISTANT GONORRHEA i Report on the enhanced surveillance of antimicrobial-resistant gonorrhea REPORT ON THE ENHANCED SURVEILLANCE OF ANTIMICROBIAL-RESISTANT GONORRHEA RESULTS FROM THE 2014 PILOT i TO PROMOTE AND PROTECT

More information

Performance of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification assays using low level controls

Performance of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification assays using low level controls Performance of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification assays using low level controls 7 th International Symposium on Molecular Diagnostics, Graz, Austria May 2008 Phillip

More information

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its

More information

APPENDIX A SERVICE SPECIFICATION

APPENDIX A SERVICE SPECIFICATION Service Specification No. Service Authority Lead Provider Lead 2013/14 APPENDIX A SERVICE SPECIFICATION Participation in the Ruclear chlamydia and gonorrhoea screening programme (General practices) Period

More information

Area Laboratory Service

Area Laboratory Service THIS IS A CONTROLLED DOCUMENT. DO NOT COPY Organisational Unit: Title: Ref No: Version No: Date Issued: Author: Authorised by: Review date: Area Laboratory Service Microbiology Scottish Toxoplasma Reference

More information

Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis Genc M, Mardh P A

Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis Genc M, Mardh P A Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis Genc M, Mardh P A Record Status This is a critical abstract of an economic evaluation that meets the

More information